Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
29
|
| pubmed:dateCreated |
1990-11-21
|
| pubmed:abstractText |
Although small in size (20 kDa), the vaccinia virus (VV) thymidine kinase protein (EC 2.7.1.21 TK) is a relatively complex enzyme which must contain domains involved in binding both substrates (ATP and thymidine) and a feedback inhibitor (dTTP), as well as sequences directing the association of individual protein monomers into a functional tetrameric enzyme. Alignment of predicted amino acid sequences of the thymidine kinase genes from a variety of sources was used to identify highly conserved regions as a first step toward locating potential regions housing essential domains. A conserved domain (domain I) near the amino terminus of VV TK protein had characteristics consistent with a nucleotide-binding site. Analysis of the nucleotide substrate specificity of VV TK indicated that ATP acts as the major phosphate donor for thymidine phosphorylation while GTP, CTP, and UTP were inefficient substrates. Site-directed mutagenesis was performed on domain I to generate 11 mutant enzymes. Comparison of the wild-type and mutant proteins with regard to enzyme activity revealed that two of the mutant enzymes, T18 and S19, exhibited enhanced enzyme activity (3.73-fold and 1.35-fold, respectively) relative to the control. The other mutations introduced led to greatly reduced levels of enzyme activity which correlated with a reduced or altered ability of the mutant enzymes to bind ATP as determined by ATP-agarose affinity chromatography. Wild-type VV TK bound to an ATP affinity column could also be eluted with dTTP. Glycerol gradient separation of wild-type TK in the presence or absence of dTTP indicated that dissociation of the tetrameric complex was not the means by which enzymatic inhibition was achieved. Taken together, these results suggest that (i) domain I (amino acids 11-22) of the VV TK corresponds to the ATP-binding site, and (ii) that dTTP is able to interfere with ATP binding, either directly or indirectly, and thereby inhibit enzymatic activity without dissociating the native enzyme.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0021-9258
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
265
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
17584-92
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:2211649-Adenosine Triphosphate,
pubmed-meshheading:2211649-Amino Acid Sequence,
pubmed-meshheading:2211649-Animals,
pubmed-meshheading:2211649-Base Sequence,
pubmed-meshheading:2211649-Binding Sites,
pubmed-meshheading:2211649-Humans,
pubmed-meshheading:2211649-Kinetics,
pubmed-meshheading:2211649-Models, Molecular,
pubmed-meshheading:2211649-Molecular Sequence Data,
pubmed-meshheading:2211649-Mutagenesis, Site-Directed,
pubmed-meshheading:2211649-Oligonucleotide Probes,
pubmed-meshheading:2211649-Protein Biosynthesis,
pubmed-meshheading:2211649-Protein Conformation,
pubmed-meshheading:2211649-Rabbits,
pubmed-meshheading:2211649-Recombinant Proteins,
pubmed-meshheading:2211649-Reticulocytes,
pubmed-meshheading:2211649-Thymidine Kinase,
pubmed-meshheading:2211649-Transcription, Genetic,
pubmed-meshheading:2211649-Vaccinia virus
|
| pubmed:year |
1990
|
| pubmed:articleTitle |
Identification of the ATP-binding domain of vaccinia virus thymidine kinase.
|
| pubmed:affiliation |
Department of Microbiology, Oregon State University, Corvallis 97331-3804.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|